Document is current
Any future updates will be listed below
-
Authors
Cescon, David W. https://orcid.org/0000-0002-1080-0998
Bratman, Scott V. https://orcid.org/0000-0001-8610-4908
Chan, Steven M.
Siu, Lillian L. https://orcid.org/0000-0002-3500-0540
-
Funding
Funding for this research was provided by:
Canadian Cancer Society Research Institute
Terry Fox Research Institute
BMO Chair in Precision Cancer Genomics
- License Information
-
More Information
Article History
Received: 2 October 2019
Accepted: 18 February 2020
First Online: 20 March 2020
Competing interests
: D.W.C. provides consultation for Agendia, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, Puma, Roche and Dynamo Therapeutics; receives research support (institutional) from GlaxoSmithKline, Merck and Pfizer; and (intellectual property) is a co-inventor on a patent related to biomarkers for TTK inhibitors (assigned to University Health Network). S.V.B. provides consultation for Bristol-Myers Squibb; receives research support from Nektar Therapeutics; and (intellectual property) is a co-inventor on a patent relating to circulating tumor DNA-mutation detection technology (PCT/US2014/02502; licensed to Roche Molecular Diagnostics) and on a patent application relating to ctDNA methylation analysis technology (PCT/CA2018/000203). S.M.C. receives honoraria from Celgene and Agios; and receives research support from Celgene, Agios and AbbVie Pharmaceuticals. L.L.S. provides consultation for Merck (compensated), Pfizer (compensated), Celgene (compensated), AstraZeneca/Medimmune (compensated), Morphosys (compensated), Roche (compensated), GeneSeeq (compensated), Loxo (compensated), Oncorus (compensated), Symphogen (compensated), Seattle Genetics (compensated), GlaxoSmithKline (compensated), Voronoi (compensated), Treadwell Therapeutics (compensated), Arvinas (compensated), Tessa (compensated), Navire (compensated); receives research support (institutional) from Novartis, Bristol-Myers Squibb, Pfizer, Boerhinger-Ingelheim, GlaxoSmithKline, Roche/Genentech, Karyopharm, AstraZeneca/Medimmune, Merck, Celgene, Astellas, Bayer, Abbvie, Amgen, Symphogen, Intensity Therapeutics, Mirati, Shattucks and Avid; and is a stockholder in Agios (spouse), Treadwell Therapeutics (spouse).
